标题
Update in the Mucopolysaccharidoses
作者
关键词
-
出版物
Seminars in Pediatric Neurology
Volume -, Issue -, Pages 100874
出版商
Elsevier BV
发表日期
2021-02-11
DOI
10.1016/j.spen.2021.100874
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms
- (2020) Gustavo M. Viana et al. Journal of Clinical Medicine
- Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease
- (2020) Bernadette Breiden et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations
- (2020) Rossella Parini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune Modulation for Enzyme Replacement Therapy in A Female Patient With Hunter Syndrome
- (2020) Daniel C. Julien et al. Frontiers in Immunology
- Treatment of mucopolysaccharidosis type II (Hunter syndrome): a Delphi derived practice resource of the American College of Medical Genetics and Genomics (ACMG)
- (2020) Kim L. McBride et al. GENETICS IN MEDICINE
- Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot study
- (2019) Agnes H. Chen et al. MOLECULAR GENETICS AND METABOLISM
- Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency
- (2018) Parisa Lotfi et al. Autophagy
- Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type B
- (2018) Chester B. Whitley et al. JOURNAL OF PEDIATRICS
- Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial
- (2018) Roberto Giugliani et al. Orphanet Journal of Rare Diseases
- Mucopolysaccharidoses: overview of neuroimaging manifestations
- (2018) Manal Nicolas-Jilwan et al. PEDIATRIC RADIOLOGY
- Intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A: A phase IIb randomized trial
- (2018) Frits A. Wijburg et al. MOLECULAR GENETICS AND METABOLISM
- Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial
- (2018) Torayuki Okuyama et al. MOLECULAR THERAPY
- Survival in idursulfase-treated and untreated patients with mucopolysaccharidosis type II: data from the Hunter Outcome Survey (HOS)
- (2017) Barbara K. Burton et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Assessments of neurocognitive and behavioral function in the mucopolysaccharidoses
- (2017) Elsa G. Shapiro et al. MOLECULAR GENETICS AND METABOLISM
- Practical management of behavioral problems in mucopolysaccharidoses disorders
- (2017) Maria L. Escolar et al. MOLECULAR GENETICS AND METABOLISM
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential Prevalence of Antibodies Against Adeno-Associated Virus in Healthy Children and Patients with Mucopolysaccharidosis III: Perspective for AAV-Mediated Gene Therapy
- (2017) Haiyan Fu et al. Human Gene Therapy Clinical Development
- Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI
- (2017) Rita Ferla et al. Molecular Therapy-Methods & Clinical Development
- A Preclinical Study Evaluating AAVrh10-Based Gene Therapy for Sanfilippo Syndrome
- (2016) Leanne K. Winner et al. HUMAN GENE THERAPY
- Treatment with pentosan polysulphate in patients with MPS I: results from an open label, randomized, monocentric phase II study
- (2016) Julia B. Hennermann et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene delivery
- (2016) Haiyan Fu et al. Molecular Therapy-Methods & Clinical Development
- Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study
- (2015) M. Aldenhoven et al. BLOOD
- A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II
- (2015) Joseph Muenzer et al. GENETICS IN MEDICINE
- Hematopoietic Stem Cell Gene Therapy Corrects Neuropathic Phenotype in Murine Model of Mucopolysaccharidosis Type II
- (2015) Taichi Wakabayashi et al. HUMAN GENE THERAPY
- Activities of daily living in patients with Hunter syndrome: Impact of enzyme replacement therapy and hematopoietic stem cell transplantation
- (2015) Julian Tanjuakio et al. MOLECULAR GENETICS AND METABOLISM
- Broad Functional Correction of Molecular Impairments by Systemic Delivery of scAAVrh74-hSGSH Gene Delivery in MPS IIIA Mice
- (2015) F Jason Duncan et al. MOLECULAR THERAPY
- A GLP-Compliant Toxicology and Biodistribution Study: Systemic Delivery of an rAAV9 Vector for the Treatment of Mucopolysaccharidosis IIIB
- (2015) Aaron S. Meadows et al. Human Gene Therapy Clinical Development
- Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial
- (2014) Marc Tardieu et al. HUMAN GENE THERAPY
- Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating Mucopolysaccharidosis IIIB: Toxicology, Biodistribution, and Immunological Assessments in Primates
- (2014) Darren A. Murrey et al. Human Gene Therapy Clinical Development
- Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning
- (2013) J. J. Boelens et al. BLOOD
- Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
- (2012) Fiona L. Wilkinson et al. PLoS One
- Genistein in Sanfilippo disease: A randomized controlled crossover trial
- (2011) Jessica de Ruijter et al. ANNALS OF NEUROLOGY
- Evaluation of Miglustat Treatment in Patients with Type III Mucopolysaccharidosis: A Randomized, Double-Blind, Placebo-Controlled Study
- (2011) Nathalie Guffon et al. JOURNAL OF PEDIATRICS
- Correction of Neurological Disease of Mucopolysaccharidosis IIIB in Adult Mice by rAAV9 Trans-Blood–Brain Barrier Gene Delivery
- (2011) Haiyan Fu et al. MOLECULAR THERAPY
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- Safe, Efficient, and Reproducible Gene Therapy of the Brain in the Dog Models of Sanfilippo and Hurler Syndromes
- (2010) N Matthew Ellinwood et al. MOLECULAR THERAPY
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search